News Agency
Men's Weekly

QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours

  • Written by PR Newswire
  • STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration's Center for Veterinary Medicine for the treatment of non-metastatic mast cell tumours (MCT) in dogs, making it the first pharmaceutical treatment available for all grades of canine non-metastatic MCT[1]
  • FDA approval follows the early 2020 marketing...

Read more: QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours

How a Shopify Web Developer Can Make or Break Your eCommerce Store

Launching an online store today is easier than ever — but building one that actually performs well, drives traffic, and converts visitors into loyal customers is a different story. While Shopify offers a beginner-friendly interface, if you want to build... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion